PURPOSEHomologous recombination deficiency (HRD) assays measure DNA damage repair dysfunction to identify patients with high-grade serous ovarian cancer (HGSOC) who may benefit from poly ADP-ribose polymerase inhibitors (PARPis). Numerous assays are …
Genentech’s PI3K inhibitor inavolisib (Itovebi) dramatically increased progression-free survival (PFS) in patients with PIK3CA-mutated, hormone receptor–positive, HER2-negative advanced or metastatic breast cancer, according to new…
In people with localized muscle-invasive bladder cancer (MIBC), extended lymph node surgery doesn’t help them live longer, a large clinical trial found.
Climate change is like cancer, delayed action leads to more suffering for patients.
Fred Hutch prostate cancer expert Dr. Andrew Hsieh won a $1M grant from the Prostate Cancer Foundation for a collaboration with the Institute of Cancer…
The Helicobacter pylori Genome Project, an international and multidisciplinary team of ~250 scientists, have sequenced the genomes and mapped the population structure of over one…
In this issue of Blood, Al-Sawaf and colleagues report on the 6-year results of the CLL14 study, a multicenter open label phase 3 trial for…
The move is part of an overhaul of decades-old mental health legislation in England and Wales.
The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or refractory microsatellite-stable metastatic colorectal cancer.
An abstract is unavailable.
The CDC endorsed the recommendation of the ACIP for people 65 and older and certain immunocompromised individuals to receive a second dose of the 2024-2025…
